NASDAQ: CTCX - Carmell Therapeutics Corporation

Yield per half year: -34.43%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Carmell Therapeutics Corporation

Extended chart Simple chart
Financial Markets by TradingView

About Carmell Therapeutics Corporation

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2023-07-17
ISIN US1429221039
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.carmellrx.com
Цена ао 0.153
Change price per day: +6.54% (0.153)
Change price per week: +6.54% (0.153)
Change price per month: +2.39% (0.1592)
Change price per 3 month: -33.74% (0.246)
Change price per half year: -34.43% (0.2486)
Change price per year: -92.05% (2.05)
Change price per 3 year: -98.32% (9.7)
Change price per year to date: -41.6% (0.2791)
All parameters

Underestimation

Title Value Grade
P/S 160.69 1
P/BV -1.72 0
P/E 0 0
EV/EBITDA -8.18 0
Total: 2.75

Efficiency

Title Value Grade
ROA, % -31.7 0
ROE, % -103.49 0
Total: 1.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.4195 10
Total: 9.6

Growth impulse

Title Value Grade
Yield Revenue, % -98.64 0
Yield Ebitda, % 310.57 10
Yield EPS, % 6.26 1
Total: 5.6
More

Institutions Volume Share, %
Meteora Capital, LLC 1743023 9.06
Vanguard Group Inc 169491 0.88
Carnegie Mellon University 103061 0.54
Geode Capital Management, LLC 89155 0.46
Linden Advisors LP 75000 0.39
Northern Trust Corporation 58358 0.3
Blackrock Inc. 31586 0.16
XTX Topco Ltd 16833 0.09
Citadel Advisors Llc 15009 0.08
Morgan Stanley 2081 0.01



Head Job title Payment Year of birth
Mr. Rajiv Sarman Shukla Executive Chairman 292.19k 1975 (50 years)
Dr. Phil Campbell Ph.D. Founder and Chief Scientific Officer N/A
Dr. Lee Weiss Ph.D. Founder N/A
Dr. James Burgess M.D. Founder N/A
Mr. Bryan J. Cassaday Chief Financial Officer 261.7k 1969 (56 years)
Ms. Kendra Bracken-Ferguson Chief Executive Officer

Address: United States, Pittsburgh. PA, 2403 Sidney Street - open in Google maps, open in Yandex maps
Website: https://www.carmellrx.com